AU2003278814A8 - Ligands for the peroxisome proliferator-activated receptor, and methods of use thereof - Google Patents

Ligands for the peroxisome proliferator-activated receptor, and methods of use thereof

Info

Publication number
AU2003278814A8
AU2003278814A8 AU2003278814A AU2003278814A AU2003278814A8 AU 2003278814 A8 AU2003278814 A8 AU 2003278814A8 AU 2003278814 A AU2003278814 A AU 2003278814A AU 2003278814 A AU2003278814 A AU 2003278814A AU 2003278814 A8 AU2003278814 A8 AU 2003278814A8
Authority
AU
Australia
Prior art keywords
ligands
methods
activated receptor
peroxisome proliferator
proliferator
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003278814A
Other versions
AU2003278814A1 (en
Inventor
Pavel Petukhov
Zhi-Liang Wei
Robert I Glazer
Alan P Kozikowski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Georgetown University
Original Assignee
Georgetown University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Georgetown University filed Critical Georgetown University
Publication of AU2003278814A8 publication Critical patent/AU2003278814A8/en
Publication of AU2003278814A1 publication Critical patent/AU2003278814A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
AU2003278814A 2002-09-13 2003-09-12 Ligands for the peroxisome proliferator-activated receptor, and methods of use thereof Abandoned AU2003278814A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41067702P 2002-09-13 2002-09-13
US60/410,677 2002-09-13
PCT/US2003/028931 WO2004024939A2 (en) 2002-09-13 2003-09-12 Ligands for the peroxisome proliferator-activated receptor, and methods of use thereof

Publications (2)

Publication Number Publication Date
AU2003278814A8 true AU2003278814A8 (en) 2004-04-30
AU2003278814A1 AU2003278814A1 (en) 2004-04-30

Family

ID=31994180

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003278814A Abandoned AU2003278814A1 (en) 2002-09-13 2003-09-12 Ligands for the peroxisome proliferator-activated receptor, and methods of use thereof

Country Status (2)

Country Link
AU (1) AU2003278814A1 (en)
WO (1) WO2004024939A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101165647B1 (en) 2003-06-20 2012-07-17 갈데르마 리써어치 앤드 디벨로프먼트 NOVEL COMPOUNDS THAT MODULATE PPARg TYPE RECEPTORS, AND USE THEREOF IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS
GB0403864D0 (en) * 2004-02-20 2004-03-24 Ucl Ventures Modulator
RU2408589C2 (en) * 2004-05-14 2011-01-10 Айрм Ллк Compounds and compositions as modulators of ppar-receptors activated by peroxisome proliferator
JP3997491B2 (en) 2004-10-29 2007-10-24 ゼリア新薬工業株式会社 Carbazole derivative, solvate thereof, or pharmaceutically acceptable salt thereof
FR2878247B1 (en) 2004-11-19 2008-10-03 Galderma Res & Dev NOVEL MODULATING COMPOUNDS OF PPARY RECEPTORS AND THEIR USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS
WO2006053791A2 (en) * 2004-11-19 2006-05-26 Galderma Research & Development Compounds that modulate ppary type receptors, and use thereof in cosmetic or pharmaceutical compositions
AR060901A1 (en) * 2006-05-12 2008-07-23 Jerini Ag HETEROCICLICAL COMPOUNDS FOR THE INHIBITION OF INTEGRINS AND USE OF THESE
JP5207972B2 (en) 2006-10-12 2013-06-12 株式会社医薬分子設計研究所 Carboxylic acid derivatives
CN102137837A (en) * 2008-04-11 2011-07-27 株式会社医药分子设计研究所 PAI-1 inhibitor
US8633245B2 (en) 2008-04-11 2014-01-21 Institute Of Medicinal Molecular Design, Inc. PAI-1 inhibitor
JP5746864B2 (en) 2008-11-19 2015-07-08 ポーラ化成工業株式会社 Wrinkle improving agent
US8987514B2 (en) 2009-02-04 2015-03-24 President And Fellows Of Harvard College Compositions and methods for labeling and imaging phospholipids
WO2022249113A1 (en) * 2021-05-25 2022-12-01 주식회사 자이메디 Novel compound inhibiting binding between aimp2-dx2 and kras, and use thereof

Also Published As

Publication number Publication date
WO2004024939A3 (en) 2004-10-14
WO2004024939A2 (en) 2004-03-25
AU2003278814A1 (en) 2004-04-30

Similar Documents

Publication Publication Date Title
IL160964A0 (en) Peroxisome proliferator activated receptor ligand and process for producing the same
AP2223A (en) Pramipexole once-daily dosage form.
HK1083831A1 (en) Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof
PL377215A1 (en) Benzimidazole derivatives and their use as vanilloid receptor ligands
AU2002335231A1 (en) Activator for peroxisome proliferator-activated receptor delta
HK1098737A1 (en) Process for the preparation of 1,1,1,3,3-pentafluoro-2-chloropropene and 1,1,1,3,3,3-hexafluoro-2-chloropropane
AU2003233010A8 (en) Process for the preparation of 3,3,4,4-tetrafluoropyrrolidine and derivatives thereof
IL165280A0 (en) 4-Substituted imidazole-2-thiones and imidazol-2-ones as agpmosts of the alpha-2b and alpha-2c adrenergic receptors
AU2003299791A1 (en) Substituted 3,5-dihydro-4h-imidazol-4-ones for the treatment of obesity
HK1167332A1 (en) Pharmaceutical composition, use thereof and method for making the same
IL162669A0 (en) Antichlinergic agents, method for producing the same and use thereof as medicaments
IL182624A0 (en) 2-amido-4 phenylthiazole derivatives, the preparation and the therapeutic use thereof
MXPA03006524A (en) Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands.
EP1482985A4 (en) Technetium-dipyridine complexes, and methods of use thereof
AU2003279442A8 (en) 2-thiohydantoine derivative compounds and use thereof for the treatment of diabetes
DK1463759T3 (en) Ligand for the G-protein-coupled receptor GPR43 and uses thereof
ZA200501288B (en) Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma.
IL161578A0 (en) Peroxisome proliferator activated receptor agonists
AU2003278814A8 (en) Ligands for the peroxisome proliferator-activated receptor, and methods of use thereof
IL166821A0 (en) Novel 1,4-diazabicycloalkane derivatives their preparation and use
AU2003290059A8 (en) Use of cd137 antagonists for the treatment of tumors
HK1079776A1 (en) The synthesis of 1,3-dihydro-2h-3-benzazepin-2-onecompounds, and the use thereof
PL1786759T3 (en) Novel derivatives of 3,5-seco-4-norcholestane and use thereof
EP1537083A4 (en) S-(-)-amlodipine nicotinate and process for the preparation thereof
GB0427568D0 (en) Particle-size reduction apparatus, and the use thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase